What question did this study set out to answer?

This review aims to summarize recent advancements in the understanding of medium-chain triglycerides (MCTs) in chronic disease prevention.

July 3, 2026NutrientsOpen Access

Recent Advances in Medium-Chain Triglycerides in Chronic Disease Prevention

View Full Paper

Ask AI

Bookmark

Authors

Review summarizes the regulatory roles of medium-chain triglycerides in chronic diseases, suggesting nutritional strategies for management.

This review aims to summarize recent advancements in the understanding of medium-chain triglycerides (MCTs) in chronic disease prevention.
Systematic review of recent research on MCTs and their mechanisms in metabolic and neurological diseases, gut health, and muscle function.
MCTs improve insulin sensitivity, aiding obesity and type 2 diabetes management.
MCTs show potential in preventing Alzheimer's and Parkinson's disease by supplying ketogenic energy and reducing inflammation.
MCTs enhance gut health by modulating microbiota and improving barrier function.

Yu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Review summarizes the regulatory roles of medium-chain triglycerides in chronic diseases, suggesting nutritional strategies for management.